Week in review: FDA updates breast-density reporting requirements | CTPA shows increased pulmonary embolism risk in omicron COVID patients | Microwave ablation with ultrasound effective for treating thyroid cancer

Dear AuntMinnie Member,

It's been a long time coming, but the U.S. Food and Drug Administration (FDA) has finally updated its mammography regulations regarding facilities' reporting of breast density information to patients.

Our top story this past week outlined the agency's effort to "ensure important information that could affect decisions about patient care, such as the potential need for further evaluation or a repeat mammogram, is communicated as completely as possible," it said. Read more in our Women's Imaging Community.

In our second most highly read story this week, we covered research about how CT pulmonary angiography (CTPA) shows an increased risk of pulmonary embolism in patients with omicron COVID-19. Check out the full details in our CT Community.

In our third most-viewed item this past week, we covered study results which suggest that microwave ablation can effectively treat papillary thyroid microcarcinoma using ultrasound to identify capsular invasion -- an approach which has been typically avoided due to safety concerns. Ultrasound also featured in our fourth top-read story of the week, in particular regarding how ultrasonic strain elastography detects liver stiffness in long-COVID-19 patients. Learn more about both of these studies in our Ultrasound Community.

Finally, our fifth most-popular article describes research that addresses the question of whether dual-layer CT can be an alternative to MRI in breast cancer staging. Navigate back to our Women's Imaging Community to get the particulars.

Page 1 of 25
Next Page